Every finding on record at A Touch of Angel Hospice Inc

Upon patient record review, 1 of 14 (Patient #3) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring #3-SN documented on SOC dated 10/01/25 that patient was taking empagliflozin 25 mg PO once daily. The medication is not on the Medication Profile.

Upon patient record review, 1 of 14 (Patient #3) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. #3-SN documented on SOC dated 10/01/25 that patient was taking empagliflozin 25 mg PO once daily. The medication is not on the Plan of Care.

Upon patient record review, 1 of 5 (Patient #1) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient #1: As observed during a home visit there was evidence that the patient was taking Losartan and using a Ventolin inhaler. Losartan and the Ventolin inhaler was not included on the medication profile. There was also evidence that Multaq and Celecoxib were discontinued prior to 10-14-22 however they were still on the medication profile.

Upon patient record review, 1 of 5 (Patient #1) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments Patient #1: As observed during a home visit the patient was taking Losartan and using a Ventolin inhaler. The record did not contain an order for Losartan and the Ventolin inhaler. There was also evidence that Multaq and Celecoxib were discontinued prior to 10-14-22 however there was no order to discontinue the Multaq and Celecoxib.